CDNA earnings — 2026-07-30

Reported the quarter ending 2026-06-30: revenue $132M, diluted EPS $2.07, net income $111M (SEC filing). Across the print the stock moved +23.4% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.